LillianCare wins impact investment to scale 400 hybrid practices.

LillianCare, a Mannheim-based healthtech startup, has closed a new investment round led by the corporate venture studio amberra, with fresh impact backing from Germany’s BONVENTURE and Spain’s Creas. The company did not disclose the total sum but said the capital will accelerate an aggressive roll-out of its hybrid primary-care model.

Founded in 2023 by healthcare leaders Linus Drop and Daniel Hefel, LillianCare combines on-site interdisciplinary teams with telemedicine, a patient app and structured pre-assessment to serve patients in underserved and rural communities. Existing backers participating in the round include Nina Capital, Calm/Storm Ventures and the impact fund Ship2B.

The financing arrives as Germany faces mounting primary-care capacity pressures. A Robert Bosch Foundation study warns of a potential shortfall of 11,000 GPs by 2035, while a 2024 OECD/European Commission report notes that over one-third of EU doctors are aged 55 or older and likely to retire in the coming years. LillianCare says its model is explicitly designed to plug gaps in access and continuity of care.

To date the startup has opened five hybrid practices in regions with high retirement exposure among physicians — notably Rhineland-Palatinate and Lower Saxony — and plans to scale quickly. Management told investors the plan is to establish 400 additional practices by 2030, using a mix of company-run sites and licensing partnerships that let independent doctors adopt LillianCare’s digital and operational stack.

Creas invested through its Creas Impacto II vehicle, which has raised in excess of €50m to date, while BONVENTURE brings additional European impact capital and sector expertise. Investors cited both the social ROI — improving rural access and lowering avoidable ER visits — and the operational leverage of a tech-enabled team-based model that can offer doctors greater schedule flexibility.

Analysts say hybrid primary-care networks are gaining traction across Europe as a pragmatic response to ageing clinician rosters and rising chronic disease burdens in non-urban areas. Early evidence indicates these models reduce patient wait times and can cut unnecessary emergency presentations by improving continuity of care in place.

Looking ahead, LillianCare plans to channel the new funds into opening clinics, strengthening its telemedicine platform, and expanding its licensing programme so practising doctors can run independent practices powered by LillianCare’s infrastructure. If execution matches ambition, the company could become a visible test case for how impact capital and digital tools can sustain primary care in ageing health systems.